Apogee Therapeutics (APGE) Other Non-Current Liabilities (2022 - 2026)

Apogee Therapeutics (APGE) has 5 years of Other Non-Current Liabilities data on file, last reported at $600000.0 in Q1 2026.

• On a quarterly basis, Other Non-Current Liabilities changed N/A year-over-year to $600000.0 in Q1 2026; TTM through Mar 2026 was $600000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $2.1 million, up 2000.0% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $600000.0, down from $2.1 million in the prior quarter.
• Over the last five years, Other Non-Current Liabilities for APGE reached as high as $8.0 million in Q4 2022 and fell as low as $100000.0 in Q4 2024.
• Historically, Other Non-Current Liabilities has averaged $3.0 million across 5 years, with a median of $2.1 million in 2025.
• Across the five-year window, Other Non-Current Liabilities slumped 98.08% in 2024 and surged 2000.0% in 2025, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $8.0 million in 2022, then plunged by 35.0% to $5.2 million in 2023, then slumped by 98.08% to $100000.0 in 2024, then jumped by 2000.0% to $2.1 million in 2025, then sank by 71.43% to $600000.0 in 2026.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $600000.0 in Q1 2026, $2.1 million in Q4 2025, and $100000.0 in Q2 2025.